|
|
|
| Webinar: Beyond Standard Approaches: Integrated Thinking for Complex FIH Programs | Platform approaches can speed standard programs, but complex molecules demand deeper, integrated thinking. In this KBI webinar, experts share real-world First-in-Human examples where cross-functional collaboration, early holistic decision-making, and downstream insight transformed technical challenges into innovation opportunities. Learn how systems-level thinking links early development choices to later-stage success and reshapes unconventional FIH development paths with confidence and clarity for teams. Click here to learn more. |
|
|
|
| Developability Assessment And Early Formulation Studies | Webinar | Coriolis Pharma | Early developability and pre‑formulation screening build strong biophysical data, reduce late‑stage risks, support candidate selection, and streamline biologics development toward clinical success. |
|
|
| 3 Keys To Success When Planning With Your CMO Partner | Article | Argonaut Manufacturing Services | Once you've identified a CMO partner, how do you ensure success? The secret: planning as early as possible – while your product is still in preclinical or clinical development. |
|
|
|
|
|
By Louis Garguilo, chief editor, Outsourced Pharma | Stephanie Wimberly graduated from Howard University in 2012 with a degree in biology. What was next? An online search turned up an intriguing area – pharmaceutical manufacturing. “It was manufacturing,” she thought, “but I could still help patients." It was a fortuitous start. This young female professional with a penchant for helping others started a manufacturing career that has wound through GSK, and leadership roles at Shire/Takeda. Now as a manufacturing consultant, here is some of her advice (for life and career). | |
|
|
|
INDUSTRY INSIGHTS CONTINUED |
|
|
|
| Liposomes — Challenges And Opportunities | Article | Pfizer CentreOne | Liposome technology is an effective drug delivery tool but still presents difficulties. Learn how developers are meeting these challenges and the opportunities for advancement to maximize liposome usefulness. |
|
|
| Flow Chemistry For Contemporary Isotope Labeling | Article | By Mounir Raji, X-Chem | Gain insight into how late‑stage exchange and flow‑based methods enable efficient access to labeled molecules for pharmaceuticals, mechanistic studies, and analytical applications. |
|
|
| Optimizing Bispecific Antibody Expression | Case Study | Asimov | Discover how diagnosing ribosome pausing sites and optimizing codon usage dramatically improves bispecific antibody titers, turning difficult-to-express candidates into viable therapeutics. |
|
|
|
|
|
|
|
| End-To-End Biologics Support | Brochure | Curia | This center offers a comprehensive suite of services for researchers seeking the discovery and engineering of potent and functional antibodies. |
|
|
|
|
|
|
Path To First-In-Human | Thermo Fisher Scientific | Unlike traditional CDMOs that stitch services together, we connect our capabilities to streamline biologics development through Path to First-in-Human. |
|
|
|
|
Your Contract Manufacturing Partner | ROIS | Our injectable and solid dosage form products are manufactured at state-of-the-art facilities located in the Madrid metropolitan area of Spain. |
|
|
Site-Specific ADC Conjugation | Abzena | Uncover efficient site-specific conjugation technology for generating ADCs and other conjugate modalities, such as AOCs and conjugates for diagnostic applications. |
|
|
Our Biotech Success | Lonza | Simon Westbrook formed an idea for a complex fusion chimera protein he believed could interrupt the neurotrophin pathway, and being a true virtual company, he needed a CDMO. |
|
|
Accelerate Your Pipeline With CDMO Collaboration | Cytiva | A CDMO can augment your capacity and expertise, refine your processes, and ultimately shorten your time to market. Look at best practices that make working with a CDMO as efficient as possible. |
|
|
|
|
|
| Explore 20+ new CDMO presenters in quick 20-minute sessions during the Outsourced Pharma Capabilities Update. Sessions include Analytical Services, ADC, Large and Small Molecules, Cell and Gene Therapy, and Fill/Finish. Each session offers a quick, informative look at capabilities to help you find the best-fit partner. Registration and on-demand access are all free! Click here to learn more. |
|
|
OUTSOURCED PHARMA CAPABILITIES UPDATE |
|
|
|
| CDMOs in biologics, cell and gene, and small molecule share their capabilities and available capabilities. See for yourself why this virtual event has become a wildly popular resource to identify options for your development and manufacturing needs. |
|
|
| Connect With Outsourced Pharma: |
|
|
|
